Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4029 | 1786 | 40.3 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
332 | 17329 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ATYPICAL HEMOLYTIC UREMIC SYNDROME | Author keyword | 115 | 76% | 4% | 80 |
2 | FACTOR H | Author keyword | 105 | 54% | 8% | 135 |
3 | C3 GLOMERULOPATHY | Author keyword | 98 | 100% | 2% | 29 |
4 | DENSE DEPOSIT DISEASE | Author keyword | 60 | 74% | 3% | 45 |
5 | ECULIZUMAB | Author keyword | 50 | 42% | 5% | 91 |
6 | FACTOR I | Author keyword | 44 | 67% | 2% | 39 |
7 | COMPLEMENT FACTOR H | Author keyword | 42 | 46% | 4% | 67 |
8 | C3 NEPHRITIC FACTOR | Author keyword | 41 | 87% | 1% | 20 |
9 | COMPLEMENT FACTOR I | Author keyword | 38 | 78% | 1% | 25 |
10 | NO MOL GENET SERV | Address | 38 | 93% | 1% | 14 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ATYPICAL HEMOLYTIC UREMIC SYNDROME | 115 | 76% | 4% | 80 | Search ATYPICAL+HEMOLYTIC+UREMIC+SYNDROME | Search ATYPICAL+HEMOLYTIC+UREMIC+SYNDROME |
2 | FACTOR H | 105 | 54% | 8% | 135 | Search FACTOR+H | Search FACTOR+H |
3 | C3 GLOMERULOPATHY | 98 | 100% | 2% | 29 | Search C3+GLOMERULOPATHY | Search C3+GLOMERULOPATHY |
4 | DENSE DEPOSIT DISEASE | 60 | 74% | 3% | 45 | Search DENSE+DEPOSIT+DISEASE | Search DENSE+DEPOSIT+DISEASE |
5 | ECULIZUMAB | 50 | 42% | 5% | 91 | Search ECULIZUMAB | Search ECULIZUMAB |
6 | FACTOR I | 44 | 67% | 2% | 39 | Search FACTOR+I | Search FACTOR+I |
7 | COMPLEMENT FACTOR H | 42 | 46% | 4% | 67 | Search COMPLEMENT+FACTOR+H | Search COMPLEMENT+FACTOR+H |
8 | C3 NEPHRITIC FACTOR | 41 | 87% | 1% | 20 | Search C3+NEPHRITIC+FACTOR | Search C3+NEPHRITIC+FACTOR |
9 | COMPLEMENT FACTOR I | 38 | 78% | 1% | 25 | Search COMPLEMENT+FACTOR+I | Search COMPLEMENT+FACTOR+I |
10 | C3 GLOMERULONEPHRITIS | 23 | 79% | 1% | 15 | Search C3+GLOMERULONEPHRITIS | Search C3+GLOMERULONEPHRITIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DENSE DEPOSIT DISEASE | 147 | 67% | 8% | 134 |
2 | FACTOR H AUTOANTIBODIES | 84 | 83% | 3% | 48 |
3 | ALTERNATIVE PATHWAY | 78 | 25% | 15% | 276 |
4 | MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS | 77 | 32% | 11% | 202 |
5 | FACTOR H MUTATIONS | 69 | 91% | 2% | 29 |
6 | SHORT CONSENSUS REPEAT | 63 | 77% | 2% | 43 |
7 | PROTEIN BETA 1H | 50 | 76% | 2% | 35 |
8 | COMPLEMENT FACTOR H | 46 | 20% | 11% | 205 |
9 | FACTOR H | 46 | 21% | 11% | 195 |
10 | HOMOZYGOUS FACTOR H | 44 | 100% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome | 2009 | 286 | 86 | 78% |
Atypical hemolytic uremic syndrome | 2011 | 111 | 141 | 81% |
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies | 2012 | 92 | 74 | 72% |
Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion | 2012 | 51 | 22 | 95% |
Membranoproliferative Glomerulonephritis - A New Look at an Old Entity | 2012 | 76 | 86 | 59% |
The human complement factor H: functional roles, genetic variations and disease associations | 2004 | 240 | 101 | 69% |
aHUS caused by complement dysregulation: new therapies on the horizon | 2011 | 48 | 99 | 85% |
Atypical Hemolytic Uremic Syndrome | 2013 | 20 | 177 | 84% |
Complement regulators and inhibitory proteins | 2009 | 283 | 103 | 31% |
Translational mini-review series on complement factor H: Genetics and disease associations of human complement factor H | 2008 | 107 | 87 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NO MOL GENET SERV | 38 | 93% | 0.8% | 14 |
2 | SERV IMMUNOL BIOL | 22 | 29% | 3.5% | 63 |
3 | JR GRP CELLULAR IMMUNOBIOL | 19 | 74% | 0.8% | 14 |
4 | RARE RENAL DIS CLIN | 15 | 88% | 0.4% | 7 |
5 | MOL OTOLARYNGOL RENAL S | 11 | 49% | 1.0% | 17 |
6 | COMPLEMENT INFLAMMAT | 11 | 36% | 1.3% | 24 |
7 | GRP BIOMOL MED | 11 | 69% | 0.5% | 9 |
8 | INFECT BIOL | 9 | 11% | 4.4% | 79 |
9 | NORTHERN MOL GENET SERV | 9 | 83% | 0.3% | 5 |
10 | COMPLEMENT DIS TEAM | 8 | 100% | 0.3% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000206226 | COMPSTATIN//COBRA VENOM FACTOR//STELLAR CHANCE S 401 |
2 | 0.0000189271 | COMPLEMENT SYNTHESIS//MRC TRANSPLANTAT TRANSPLANTAT IMMUNOL M//COMPLEMENTO |
3 | 0.0000152059 | CD59//CRRY//CD55 |
4 | 0.0000137232 | C2 DEFICIENCY//COMPLEMENT GENETICS//COMPLEMENT AND INFLAMMATION |
5 | 0.0000124257 | C8 ALPHA//C8 GAMMA//PROPERDIN DEFICIENCY |
6 | 0.0000107659 | COMPLEMENT RECEPTOR 1//COMPLEMENT RECEPTOR TYPE 1//CR1 |
7 | 0.0000101390 | C3 AND C4//COMPLEMENT AND INFLAMMATION//LUPUS EXCELLENCE |
8 | 0.0000097608 | T ACTIVATION//POLYAGGLUTINATION//ERYTHROCYTE CHARGE |
9 | 0.0000079235 | THROMBOTIC THROMBOCYTOPENIC PURPURA//ADAMTS 13//TTP |
10 | 0.0000079033 | CD21//COMPLEMENT RECEPTOR 2//CR2 |